Literature DB >> 8011387

Evaluation of lipomatous soft tissue tumors by MR imaging.

J Gelineck1, J Keller, O Myhre Jensen, O S Nielsen, T Christensen.   

Abstract

Large soft tissue tumors--5 cm or greater--or deep-seated tumors have a greater risk of being malignant than smaller and superficially located tumors (9). In a period of 2 years 43 consecutive patients with lipomatous tumors 5 cm in diameter or greater were examined with MR imaging. The MR findings were correlated to histologic features and diagnosis. Twenty-six tumors were classic lipomas both on MR and at microscopy; 8 lipomas showed other features--some of them raising suspicion of malignancy at MR; all, however, were histologically benign. Nine tumors were considered malignant at MR imaging; all 9 proved to be malignant by microscopy.

Entities:  

Mesh:

Year:  1994        PMID: 8011387

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  4 in total

1.  Lipomatous Tumors: A Comparison of MRI-Reported Diagnosis with Histological Diagnosis.

Authors:  Tobias M Ballhause; Alexander Korthaus; Martin Jahnke; Karl-Heinz Frosch; Jin Yamamura; Tobias Dust; Carsten W Schlickewei; Matthias H Priemel
Journal:  Diagnostics (Basel)       Date:  2022-05-21

2.  Predictive value of gadolinium enhancement in differentiating ALT/WD liposarcomas from benign fatty tumors.

Authors:  M J Panzarella; A H Naqvi; H E Cohen; T A Damron
Journal:  Skeletal Radiol       Date:  2005-03-02       Impact factor: 2.199

3.  Unilateral Giant Vulvar Lipoma with Fat Necrosis Not Visualized on Magnetic Resonance Imaging (MRI).

Authors:  Shuang Li; Terry Haag; Jeannie McWhorter; Li Ge; Steve J Carlan
Journal:  Am J Case Rep       Date:  2019-11-27

4.  MRI-based radiomics to predict lipomatous soft tissue tumors malignancy: a pilot study.

Authors:  Benjamin Leporq; Amine Bouhamama; Frank Pilleul; Fabrice Lame; Catherine Bihane; Michael Sdika; Jean-Yves Blay; Olivier Beuf
Journal:  Cancer Imaging       Date:  2020-10-28       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.